Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_assertion type Assertion NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_head.
- NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_assertion description "[Importantly, LATS1 signaling was disrupted by 17-AAG in tumor cell lines in vitro and clinical ovarian cancers in vivo as shown by reduced levels of LATS1 and decreased phosphorylation of the LATS substrate YAP, an oncoprotein transcriptional coactivator that regulates genes involved in cell and tissue growth, including the CTGF gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_provenance.
- NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_assertion evidence source_evidence_literature NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_provenance.
- NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_assertion SIO_000772 20841485 NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_provenance.
- NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_assertion wasDerivedFrom befree-20150227 NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_provenance.
- NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_assertion wasGeneratedBy ECO_0000203 NP917361.RACxlNsHhiqEe_pbVviV6LM7JQaaCqa6O7G2d0nIp8yj4130_provenance.